Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
X4 Pharmaceuticals, Inc. (XFOR) had Return on Equity of -169.08% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$2.56M |
|
$-37.45M |
|
$0.80M |
|
$1.76M |
|
$38.96M |
|
$-36.40M |
|
$-0.74M |
|
$-37.14M |
|
$-37.14M |
|
$-37.45M |
|
$-37.45M |
|
$-37.45M |
|
$-37.45M |
|
$-36.40M |
|
$-35.60M |
|
6.70M |
|
6.70M |
|
$-5.71 |
|
$-5.71 |
|
| Balance Sheet Financials | |
$112.17M |
|
$0.78M |
|
$34.27M |
|
$146.45M |
|
$32.88M |
|
$75.42M |
|
$91.42M |
|
$124.30M |
|
$22.15M |
|
$-5.20M |
|
$22.15M |
|
5.69M |
|
| Cash Flow Statement Financials | |
$-130.90M |
|
$66.99M |
|
$20.29M |
|
$100.25M |
|
$56.48M |
|
$-43.77M |
|
$8.20M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.41 |
|
-- |
|
-- |
|
0.77 |
|
3.41 |
|
68.83% |
|
-1423.58% |
|
-1423.58% |
|
-1392.45% |
|
-1452.48% |
|
-1464.61% |
|
$-26.23M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
0.28 |
|
1.50 |
|
244.09 |
|
|
Return on Equity |
-169.08% |
719.92% |
|
-25.57% |
|
-38.38% |
|
$3.89 |
|
$-3.92 |
|
$-19.55 |
|